Not Tagged
molecular therapeutics
['biomarker']
interested in biomarkers of response of novel molecular therapeutics at #aacr23? icymi in : #fgfr2 ecd in-frame deletions are therapeutically targetable genomic alterations that function as oncogenic drivers in #cholangiocarcinoma 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her